Helping your patients breathe their best

New Otrivine Fine Nasal Mist*

New Otrivine Fine Nasal Mist*

Patients can find nasal congestion treatments uncomfortable for a number of reasons. These include but are not limited to: 1-3

  • Discomfort and irritation
  • Lack of control around dosage due to actuation
  • Drippage down the throat
  • Irritation/unpleasant aftertaste
  • Discomfort with the size of spray droplets
  • An unergonomic design

Otrivine fine nasal mist* has been researched, developed, and created to help overcome these issues, to improve the customer experience when using a nasal spray.

Otrivine new nasal mist is suitable for adults and children (aged 12 or older).

Read more below to understand how it can help different patient groups.

*New nozzle provides fine mist

Otrivine Patient Profile

Comfortable congestion relief with a new spray nozzle

Lauren suffers from nasal congestion due to sinusitis. Nasal congestion affects her sleep at night and as a result her performance at work.

And, due to unpleasant experiences in the past, she does not like using nasal sprays. However she is also not keen to take tablets and is seeking fast congestion relief. Find out how New Otrivine Fine Nasal Mist* can help.

*New nozzle provides fine mist

Otrivine Patient Profile

Treating nasal congestion in children & adolescents aged 12 years+

Jane’s 13 year-old daughter is suffering from a blocked nose due to a cold. This means she is breathing through her mouth and night and struggling to stay asleep.

Jane has been recommended a nasal spray by a local pharmacist; however, her daughter is finding it uncomfortable when placed in her nostrils.

  • Pack shot of Otrivine Fine Nasal Mist showing spray

    Patented Technology

    A new, patented technology, delivers a fine mist which feels comfortable and gentle in the nose.2,4 This ensures greater comfort and an overall better experience for users vs. the previous device.1,4 The fine mist also provides greater coverage of the nasal mucosa vs the previous device.2

    †Patent number EP2654967B1

    Targeted congestion relief

    New mist delivery, same trusted formulation*

    The fine mist from the nasal spray reaches wide to inflamed areas in the nasal cavity, providing congestion relief.2

    *vs previous device

    Image of the spray in the nose showing design not to drip at the back of the throat

    Designed not to drip at the back of the throat

    A lateral actuation system is designed not to drip down the throat after use. The fine mist covers the nasal mucosa, staying in the nose, instead of dripping down the back of the throat – highlighted as a potential reason for not using nasal sprays.2

  • New ergonomic design

    New ergonomic design

    A new design, means New Otrivine Fine Nasal Mist* may be more comfortable and easy to use compared to the previous device.3,4

    *new nozzle provides fine mist

    1-button action

    1-button action

    Easy and controlled administration with a single push of a button.2-4

    Protective cap

    Protective cap

    This easy-to-use cap protects the nozzle in between uses to maintain hygiene.

  • Product Information – Otrivine Congestion Relief

    Otrivine Congestion Relief 0.1% Nasal Spray. (Xylometazoline Hydrochloride).

    Indications: For the symptomatic relief of nasal congestion, perennial and allergic rhinitis (including hay fever) and sinusitis.

    Dosage: Adults and adolescents over 12 years of age: 1 spray into each nostril, up to 3 times daily as needed. Do not exceed 3 applications daily into each nostril. Do not use in children under 12.

    Contraindications: Hypersensitivity to the active substance or to any of the excipients. Trans-sphenoidal hypophysectomy or surgery exposing the dura mater, narrow-angle glaucoma, rhinitis sicca or atrophic rhinitis, phaeochromocytoma, prostatic hypertrophy, patients on MAOI treatment or who have received them in the last two weeks. Do not use in children under 12 years.

    Warnings and precautions: Do not take for more than seven consecutive days. Use with caution in patients showing a strong reaction to adrenergic substances, with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus and those taking tri and tetra-cyclic antidepressant treatment. Patients with long QT syndrome may be at increased of serious ventricular arrhythmias. This medicine contains polyoxyl hydrogenated castor oil which may cause skin reactions.

    Side effects: See SPC for full details. Common: Application site burning, nausea, headache, nasal dryness and nasal discomfort.

    MRSP (excl. VAT): £5

    Legal Status: GSL.

    Licence Number: PL 44673/0151.

    Licence Holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, U.K.

    Date of revision: Jan 2024.

Otrivine – your Nasal Health Partner

Otrivine final nasal mist

Otrivine Fine Nasal Mist*

Learn more about Otrivine Fine Nasal Mist*.

*New nozzle provides fine mist

Find out more

Otrivine logo

The Otrivine range

Find out how the Otrivine range can help your patients.

Find out more

Icon for educational resources

Educational resources

Access video and interactive content for pharmacy on respiratory health.

Access resources

Webinars

Webinars

Find out more about upcoming live webinars.

Find out more

Patient care resources

Patient care resources

Download resources for your patients.

Find out more

Icon of a nose

Respiratory health conditions

Discover information on other respiratory health conditions including allergy and smokers health.

Read more